➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Dow
Mallinckrodt
Colorcon
Express Scripts

Last Updated: July 24, 2021

DrugPatentWatch Database Preview

Details for Patent: 8,580,830


Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,580,830 protect, and when does it expire?

Patent 8,580,830 protects ZUPLENZ and is included in one NDA.

This patent has eighteen patent family members in fourteen countries.

Summary for Patent: 8,580,830
Title:Non-mucoadhesive film dosage forms
Abstract: Orally disintegrating film dosage forms for delivering active pharmaceutical agents, methods of formulating the dosage forms to retard absorption through the oral mucosa, and methods of using the dosage forms for the treatment of various medical conditions are provided.
Inventor(s): Leichs; Christian (Alfdorf, DE), Breitenbach; Armin (Leverkusen, DE), Lehrke; Ingo (Cologne, DE), Galfetti; Paolo (Comasco, IT)
Assignee: Labtec GmbH (DE) APR Applied Pharma Research S.A. (CH)
Application Number:12/443,414
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Compound;

Drugs Protected by US Patent 8,580,830

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Aquestive ZUPLENZ ondansetron FILM;ORAL 022524-001 Jul 2, 2010 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Aquestive ZUPLENZ ondansetron FILM;ORAL 022524-002 Jul 2, 2010 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,580,830

PCT Information
PCT FiledOctober 02, 2007PCT Application Number:PCT/EP2007/008579
PCT Publication Date:April 10, 2008PCT Publication Number: WO2008/040534

International Family Members for US Patent 8,580,830

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2007304425 ⤷  Free Forever Trial
Brazil PI0719840 ⤷  Free Forever Trial
Canada 2664986 ⤷  Free Forever Trial
China 101626756 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Harvard Business School
Colorcon
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.